$0.7435
0.04866.99%
最終更新: Oct 27, 2:00 PM
Benzinga
Benzinga
Benzinga
火曜日, 10 27
Benzinga
© 2026 Benzinga | All Rights Reserved
Cognition Therapeutics (CGTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.06 | $-0.07 | $-0.07 | $-0.08 |
| Actual | $-0.04 | $-0.05 | $-0.01 | $-0.06 |
| Surprise | +33.3% | +28.6% | +85.7% | +25.0% |
| Revenue | ||||
| Estimate | $1.0M | $880000 | — | — |
| Actual | $0 | $0 | — | — |
| Surprise | -100.0% | -100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.14 | $-0.05 | $-0.05 |
| Revenue | ||||
| Consensus | $1.1M | $800000 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.04 | $-0.06 | 33.3 % |
| Q1 | May 7, 2026 | $-0.05 | $-0.07 | 28.6 % |
| Q4 | Mar 26, 2026 | $-0.01 | $-0.07 | 85.7 % |
| Q3 | Nov 6, 2025 | $-0.06 | $-0.08 | 25.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $1.00M | -100.0 % |
| Q1 | May 7, 2026 | $0 | $880.00K | -100.0 % |